With the public availability of ChatGPT 3.5 in fall 2022 at the latest, artificial intelligence in the sense of large language models (LLMs) is on everyone’s lips. However, it is often forgotten that this is only the provisional end point of decades of development of artificial intelligence, which, despite its great potential, still has many limitations. The question for practising doctors is how this technology can be used sensibly in everyday clinical practice – and how it should not be used.
Autoren
- Dr. med. Lukas Dürst
- Dr. med. Marc Oertle
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- GLP1-RA therapy
Improvement in either weight or HbA1c – but never both
- Suicide
Dealing with trauma after suicide loss: What do bereaved people experience as effective?
- COPD exacerbations
Fast therapy initiation is not much better than expected
- Galenic systems
Advantages of topical pharmacotherapy – Update 2025
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Psychedelics and related drug classes
Ritual, party or new therapy? Psychedelics and more: clinically illuminated
- Acute sinusitis: real-world study on first-line therapy
Focusing on a rational therapeutic approach beyond antibiotics
- DOAK optimization, ABC pathway and lessons learned from the FXI/XIa pipeline